@entity2622 and endometrium are common gynecologic @entity5 . Both @entity189 are staged and managed by means of the International Federation of Gynecology and Obstetrics (FIGO) staging system. In @entity5 , the FIGO staging system is determined preoperatively by limited conventional procedures. Although this system is effective for early stage disease, it has inherent inaccuracies in advanced stage diseases and does not address nodal involvement. CT and MR imaging are widely used as comprehensive imaging modalities to evaluate @entity5 size and extent, and nodal involvement. MR imaging is an excellent modality for depicting invasive @entity2622 and can provide objective measurement of @entity5 volume, and provides high negative predictive value for parametrial invasion and @entity3480 . In contrast, @entity1204 is surgically staged. Beside recognition of the important prognostic factors, including histologic subtype and grade, accurate assessment of the @entity5 extent on preoperative MR imaging is expected to greatly optimize surgical procedure and therapeutic strategy. Contrast-enhanced MR imaging can offer "one stop" examination for evaluating the depth of myometrial invasion cervical invasion and nodal metastases. Evaluation of myometrial invasion on MR imaging may be an alternative to gross inspection of the uterus during the surgery.

Staging of XXXX and endometrium.

@entity1204 :: ('MESH:D016889', 'Disease') :: ['endometrial cancer'] @entity3480 :: ('MESH:C538167', 'Disease') :: ['stage IVA disease'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'malignancies', 'uterine cervical cancer'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['Carcinoma of the uterine cervix', 'cervical carcinoma'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinomas']
@entity2622 :: (MESH:D002583,Disease) :: ['carcinoma of the uterine cervix']
